Pathophysiology of Alpha-1 Antitrypsin Deficiency Liver Disease
- PMID: 28752441
- DOI: 10.1007/978-1-4939-7163-3_1
Pathophysiology of Alpha-1 Antitrypsin Deficiency Liver Disease
Abstract
Classical alpha-1 antitrypsin (a1AT) deficiency is an autosomal recessive disease associated with an increased risk of liver disease in adults and children, and with lung disease in adults (Teckman and Jain, Curr Gastroenterol Rep 16(1):367, 2014). The vast majority of the liver disease is associated with homozygosity for the Z mutant allele, the so-called PIZZ. These homozygous individuals synthesize large quantities of a1AT mutant Z protein in the liver, but the mutant protein folds improperly during biogenesis and approximately 85% of the molecules are retained within the hepatocytes rather than appropriately secreted. The resulting low, or "deficient," serum level leaves the lungs vulnerable to inflammatory injury from uninhibited neutrophil proteases. Most of the mutant Z protein molecules retained within hepatocytes are directed into intracellular proteolysis pathways, but some molecules remain in the endoplasmic reticulum for long periods of time. Some of these molecules adopt an unusual aggregated or "polymerized" conformation (Duvoix et al., Rev Mal Respir 31(10):992-1002, 2014). It is thought that these intracellular polymers trigger a cascade of intracellular injury which can lead to end-organ liver injury including chronic hepatitis, cirrhosis, and hepatocellular carcinoma (Lindblad et al., Hepatology 46(4):1228-1235, 2007). The hepatocytes with the largest accumulations of mutant Z polymers undergo apoptotic death and possibly other death mechanisms. This intracellular death cascade appears to involve ER stress, mitochondrial depolarization, and caspase cleavage, and is possibly linked to autophagy and redox injury. Cells with lesser burdens of mutant Z protein proliferate to maintain the liver cell mass. This chronic cycle of cell death and regeneration activates hepatic stellate cells and initiates the process of hepatic fibrosis. Cirrhosis and hepatocellular carcinoma then result in some patients. Since not all patients with the same homozygous PIZZ genotype develop end-stage disease, it is hypothesized that there is likely to be a strong influence of genetic and environmental modifiers of the injury cascade and of the fibrotic response.
Keywords: Alpha-1 antitrypsin; Cirrhosis; ER stress; Fibrosis; Hepatocellular carcinoma; Liver; Pathology; Polymers; Proliferation.
Similar articles
-
Semiquantitation of Monomer and Polymer Alpha-1 Antitrypsin by Centrifugal Separation and Assay by Western Blot of Soluble and Insoluble Components.Methods Mol Biol. 2017;1639:227-234. doi: 10.1007/978-1-4939-7163-3_23. Methods Mol Biol. 2017. PMID: 28752463
-
Liver disease in alpha-1 antitrypsin deficiency: current understanding and future therapy.COPD. 2013 Mar;10 Suppl 1:35-43. doi: 10.3109/15412555.2013.765839. COPD. 2013. PMID: 23527737 Review.
-
Alpha-1 antitrypsin and liver disease: mechanisms of injury and novel interventions.Expert Rev Gastroenterol Hepatol. 2015 Feb;9(2):261-8. doi: 10.1586/17474124.2014.943187. Epub 2014 Jul 28. Expert Rev Gastroenterol Hepatol. 2015. PMID: 25066184 Review.
-
Alpha-1-antitrypsin mutant Z protein content in individual hepatocytes correlates with cell death in a mouse model.Hepatology. 2007 Oct;46(4):1228-35. doi: 10.1002/hep.21822. Hepatology. 2007. PMID: 17886264
-
Advances in alpha-1-antitrypsin deficiency liver disease.Curr Gastroenterol Rep. 2014 Jan;16(1):367. doi: 10.1007/s11894-013-0367-8. Curr Gastroenterol Rep. 2014. PMID: 24338605 Review.
Cited by
-
Alpha-1-antitrypsin: A possible host protective factor against Covid-19.Rev Med Virol. 2021 Mar;31(2):e2157. doi: 10.1002/rmv.2157. Epub 2020 Aug 26. Rev Med Virol. 2021. PMID: 32844538 Free PMC article. Review.
-
Alpha-1 Antitrypsin Induces Epithelial-to-Mesenchymal Transition, Endothelial-to-Mesenchymal Transition, and Drug Resistance in Lung Cancer Cells.Onco Targets Ther. 2020 May 4;13:3751-3763. doi: 10.2147/OTT.S242579. eCollection 2020. Onco Targets Ther. 2020. PMID: 32440144 Free PMC article.
-
Liver fibrosis: Pathophysiology and clinical implications.WIREs Mech Dis. 2021 Jan;13(1):e1499. doi: 10.1002/wsbm.1499. Epub 2020 Jul 26. WIREs Mech Dis. 2021. PMID: 32713091 Free PMC article. Review.
-
The Mechanism of Mitochondrial Injury in Alpha-1 Antitrypsin Deficiency Mediated Liver Disease.Int J Mol Sci. 2021 Dec 9;22(24):13255. doi: 10.3390/ijms222413255. Int J Mol Sci. 2021. PMID: 34948056 Free PMC article.
-
Posttransplant Lymphoproliferative Disorder in a Patient With Alpha-1 Antitrypsin Deficiency: A Case Report.Cureus. 2024 Jun 10;16(6):e62107. doi: 10.7759/cureus.62107. eCollection 2024 Jun. Cureus. 2024. PMID: 38993443 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials